MHRA (Medicines and Healthcare Products Regulatory Agency) ran a consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and on the risk minimisation…
The Society responded to the MHRA’s consultation on licensing of homeopathic medicines. This position was published in 2007 as part of a HealthWatch paper on ‘the regulation of…
The Society responded to the discussion paper by NHS England presenting proposals which have been developed working with a range of stakeholders, on the establishment of the four…
The National Institute for Health and Care Excellence (NICE) has consulted on the scope (i.e. what aspects of care the guideline will cover and to whom it will apply) of the clinical…
The House of Lords Science & Technology Committee recommended the Research Council UK’s (RCUK) policy on open access be revised to improve the clarity of the policy. The…
The Commons Select Science and Technology Committee held an inquiry into antimicrobial resistance. BPS responded to highlight the need to incentivise development of new…
The Commons Select Science and Technology Committee held an inquiry on the ‘leaky pipeline’ i.e. the continuous loss of women at consecutive career stages within STEM industries. The…
The Society responded to the Science communication inquiry of the House of Commons Science and Technology Committee. The inquiry looked into how the Government, scientists, the media…
The Finch Group met in September 2013 to review progress in implementing the recommendations from the report. In order to inform this review meeting, we responded to the Society of…
The Society had conributed to the Royal Society of Biology's response to the Teaching Excellence Framework technical consultation for year 2. This consultation, which was published…
